Publications by authors named "K Harrington"

Claim this Profile
S
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study.
Kevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, Jessica L Geiger, Marc Oliva

Oral Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Concussions Among High-School Athletes in School-Sponsored Sports: Implications for Safety.
Helen J Kemprecos, Annabelle Shaffer, Zelda Moran, Aaron T Anderson, Kelly Harrington

Neurosurgery· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INDUCE-3: A randomized Phase II/III study of first-line feladilimab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Danny Rischin, Aaron R Hansen, Ezra E W Cohen, Makoto Tahara, Kevin J Harrington

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-event endpoints (EFS2, PRFS2 and PFS2) after anti-PD-(L)1-based RCTs: a systematic review and meta-analysis.
Pablo Jimenez-Labaig, Oriol Mirallas, Ana Isabel Martin-Quesada, Antonio Rullan, Dario Trapani, Kevin J Harrington

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Support of a Patient Navigator Program for Diabetic Foot Ulcer Care: A Qualitative Thematic Analysis and Pilot Studies.
Rebekah N Williams, Jesica M Flores, Kristin Harrington, Aliza Morani, Tejaswini Agarwal

medRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis